ForSight Robotics raises $125 million Series B
ForSight Robotics completed a $125 million Series B to advance clinical development and commercialisation of its ophthalmic surgical-robotics platform.
Evidence notes
- Series B: USD 125,000,000.
- Eclipse led or provided the financing.
- ForSight Robotics completed a $125 million Series B to advance clinical development and commercialisation of its ophthalmic surgical-robotics platform.
Company context
ForSight Robotics develops JASPER, a robotic platform for ophthalmic surgery. The system combines microsurgical robotics, visualisation and surgeon controls to improve precision and expand access to eye procedures.